Medicare Enrolled
Dr. David Henderson, M.D.
Cardiovascular Disease · Daytona Beach, FL
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Henderson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Henderson? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Henderson
Dr. David Henderson is a cardiovascular disease in Daytona Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Henderson performed 9,032 Medicare services across 5,013 unique beneficiaries.
Between the years covered by Open Payments, Dr. Henderson received a total of $107,810 from 43 pharmaceutical and/or device companies across 523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Henderson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 9% volume in FL$ $107,810 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,032
Medicare services
Top 9% in FL for cardiovascular disease
5,013
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~475 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 2,052 | $61 | $148 |
| Regadenoson injection (Lexiscan) for heart stress test | 747 | $44 | $493 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 663 | $28 | $82 |
| Remote pacemaker/defibrillator monitoring, 90 days | 631 | $16 | $50 |
| Remote pacemaker monitoring, 90 days | 439 | $22 | $55 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 418 | $20 | $51 |
| Office visit, established patient (30-39 min) | 354 | $99 | $251 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 333 | $317 | $846 |
| Echocardiogram, transthoracic | 327 | $145 | $418 |
| Electrocardiogram (EKG), 12-lead | 271 | $11 | $30 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 258 | $20 | $49 |
| Hospital follow-up visit, moderate complexity | 215 | $64 | $135 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 209 | $51 | $148 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 197 | $27 | $81 |
| Programming of dual lead pacemaker system | 178 | $58 | $166 |
| Hospital follow-up visit, low complexity | 172 | $40 | $74 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 168 | $1,183 | $3,187 |
| Nuclear medicine study of heart muscle blood flow by pet | 120 | $142 | $376 |
| New patient office visit (30-44 min) | 94 | $78 | $192 |
| Ultrasound of both sides of head and neck blood flow | 93 | $135 | $412 |
| Office visit, established patient (10-19 min) | 92 | $41 | $93 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 80 | $359 | $779 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 76 | $624 | $1,199 |
| Initial hospital admission, moderate complexity | 75 | $105 | $234 |
| Programming of multiple lead implantable defibrillator system | 71 | $82 | $225 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 70 | $20 | $35 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 67 | $10 | $90 |
| Ultrasound scan of abdominal aorta | 47 | $102 | $229 |
| New patient office visit (45-59 min) | 45 | $124 | $297 |
| Cardiac catheterization | 43 | $211 | $869 |
| Programming of single lead pacemaker system | 42 | $49 | $141 |
| Programming of cardiac rhythm monitor system | 42 | $43 | $83 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 42 | $68 | $163 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $335 | $958 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 37 | $19 | $56 |
| Heart rhythm recording of continous external ekg over 8-15 days | 34 | $9 | $30 |
| Hospital follow-up visit, high complexity | 31 | $96 | $207 |
| Programming of dual lead implantable defibrillator system | 29 | $66 | $204 |
| Initial hospital admission, high complexity | 29 | $140 | $353 |
| Programming of single lead implantable defibrillator system | 24 | $64 | $170 |
| External shock to heart to regulate heart beat | 22 | $82 | $211 |
| Coronary stent placement | 16 | $443 | $873 |
| Insertion of heart rhythm monitor under skin | 14 | $3,326 | $6,993 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $164 | $291 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $263 | $993 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.2% high complexity
15.8% medium
62.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$107,810
Total received (2018-2024)
Avg $15,401/year across 7 years
Top 4% in FL for cardiovascular disease
43
Companies
523
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$56,313 (52.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$42,743 (39.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,754 (8.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,715
2023$1,742
2022$2,700
2021$36,103
2020$4,063
2019$17,673
2018$43,813
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$39,858
Janssen Pharmaceuticals, Inc
$34,545
Esperion Therapeutics, Inc.
$18,783
SANOFI-AVENTIS U.S. LLC
$6,212
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,346
Medtronic Vascular, Inc.
$2,041
Novartis Pharmaceuticals Corporation
$427
Amgen Inc.
$378
CVRx, Inc.
$354
Medtronic, Inc.
$330
PFIZER INC.
$253
ATRICURE, INC.
$150
Impulse Dynamics (USA) Inc.
$77
Novo Nordisk Inc
$74
Philips North America LLC
$70
Kowa Pharmaceuticals America, Inc.
$69
ABIOMED
$64
Boston Scientific Corporation
$60
AstraZeneca Pharmaceuticals LP
$55
Kestra Medical Technology Services, Inc.
$54
E.R. Squibb & Sons, L.L.C.
$52
Bardy Diagnostics, Inc.
$48
PORTOLA PHARMACEUTICALS, INC.
$44
Regeneron Healthcare Solutions, Inc.
$42
Opsens Inc.
$40
Braemar Manufacturing, LLC
$38
Philips Electronics North America Corporation
$37
Merck Sharp & Dohme LLC
$36
Gilead Sciences, Inc.
$31
Acist Medical Systems, Inc.
$26
iRhythm Technologies, Inc.
$25
Bayer HealthCare Pharmaceuticals Inc.
$23
Astellas Pharma US Inc
$22
AtriCure, Inc.
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$17
Amarin Pharma Inc.
$16
Alnylam Pharmaceuticals Inc.
$16
Circassia Pharmaceuticals Inc
$15
Teleflex LLC
$15
Actelion Pharmaceuticals US, Inc.
$13
ARALEZ PHARMACEUTICALS US INC.
$12
Allergan Inc.
$12
Aziyo Biologics, Inc.
$11
Top 3 companies account for 86.4% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (CM9) Amb Mon & Diag Und · AMPLATZER AMULET · AMPLATZER TALISMAN · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · Accent Pacemaker · Advisa · Allure CRT Pacemaker · Anthem CRT Pacemaker · Assure WCD · Azure · BEVYXXA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CLOSUREFAST · CONFIRM RX · CRT Leads · CVI Systems · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink Express · Carnation Ambulatory Monitor · Confirm Rx · Consulta · Corlanor · DxTerity · ECM Patch · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Ellipse ICD · Endurity Pacemaker · Ensite Cardiac Mapping System · FARXIGA · Fortify Assura · HAWKONE · HawkOne · HeartMate · IN.PACT ADMIRAL · INNOVA · Impella · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LifeVest · Livalo · MULTAQ · Merlin Connectivity and Remote · NEXLETOL · NEXLIZET · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPTIMIZER · OptiSense Pacing Lead · Optimizer · Optimizer Smart System · Optowire · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pouch · Prolia · Quadra Allure MP RF CRT Pacemkr · Quartet CRT Lead · RESOLUTE ONYX · Repatha · Resolute · Reveal LINQ · Rybelsus · SPIDERFX · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRAPLINER · TUDORZA PRESSAIR · Tendril Pacing Lead · Trilogy 100 · VERQUVO · Vascepa · Visia AF · Viva · WATCHMAN · Wegovy · XARELTO · ZIO Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for cardiovascular disease in FL.
Equivalent to $1,194 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
32
Per 100K population
5.6
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Henderson is a remote & electrophysiology specialist, with above-average Medicare volume (top 9% in FL), and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Henderson experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Henderson performed 2,052 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Henderson receive payments from pharmaceutical companies?
Yes. Dr. Henderson received a total of $107,810 from 43 companies across 523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Henderson's costs compare to other cardiovascular diseases in Daytona Beach?
Dr. Henderson's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Henderson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Daytona Beach
Browse cardiovascular diseases in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Esperion Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Esperion Therapeutics, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology